[1] SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2019［J］.CA:A Cancer Journal for Clinicians,2019,69(1):7-34.
[2] PFAENDLER KS,TEWARI KS.Changing paradigms in the systemic treatment of advanced cervical cancer ［J］.American Journal of Obstetrics and Gynecology,2016,214(1):22-30.
[3] HOWLADER N,NOONE AM,KRAPCHO M,et al.SEER cancer statistics review,1975-2016［J/OL］.National Cancer Institute:Bethesda,MD,2019,4:8(2020-04-09).https://seer.cancer.gov/csr/1975-2016/.DOI:10.4236/ojog.2019.95065.
[4] REDDY T,GIBBS GM,KERR J,et al.Cysteine-rich secretory proteins are not exclusively expressed in the male reproductive tract ［J］.Developmental Dynamics,2008,237:3313-3323.
[5] XU HH,WANG K,FENG XH,et al.Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China:a systematic review and meta-analysis ［J］.Oncotarget,2018,9(20):15386-15397.
[6] MEDI K,KAZIM YA,CRAIG M.Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective ［J］.PLoS One,2018,13(7):e0200717.
[7] BARRETT T,WILHITE SE,LEDOUX P,et al.NCBI GEO:archive for functional genomics data sets-update ［J］.Nucleic Acids Research,2013,41(Database issue):991-995.
[8] KJELDSEN L.Gelatinase granules in human neutrophils ［J］.European Journal of Haematology,1995,56:1-30.
[9] KRATZSCHMAR J,HAENDLER B,EBERSPAECHER U,et al.The human cysteine-rich secretory protein(CRISP) family.Primary structure and tissue distribution of CRISP-1,CRISP-2 and CRISP-3 ［J］.European Journal of Biochemistry,1996,236:827-836.
[10] UDBY L,BJARTELL A,MALM J,et al.Characterization and localization of cysteine-rich secretory protein 3(CRISP3) in the human male reproductive tract ［J］.Journal of Andrology,2005,26:333-342.
[11] HAENDLER B,TODA I,SULLIVAN DA,et al.Expression of transcripts for cysteine-rich secretory proteins(CRISPs) in the murine lacrimal gland ［J］.Journal of Cellular Physiology,1999,178:371-378.
[12] UDBY L,CALAFAT J,SORENSEN OE,et al.Identification of human cysteine-rich secretory protein 3(CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils ［J］.Journal of Leukocyte Biology,2002,72:462-469.
[13] UDBY L,COWLAND JB,JOHNSEN AH,et al.An ELISA for SGP28/CRISP-3,a cysteine-rich secretory protein in human neutrophils,plasma,and exocrine secretions ［J］.Journal of Immunological Methods,2002,263:43-55.
[14] JEMMA E,REBECCA DS,MARIANNA V,et al.Endometrial CRISP3 is regulated throughout the mouse estrous and human menstrual cycle and facilitates adhesion and proliferation of endometrial epithelial cells ［J］.Biology of Reproduction,2015,92(4):1-10.
[15] TALBI S,HAMILTON AE,VO KC,et al.Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women ［J］.Endocrinology,2006,147:1097-1121.
[16] HORNE AW,DUNCAN WC,KING AE,et al.Endometrial cysteine-rich secretory protein 3 is inhibited by humanchorionic gonadotrophin,and is increased in the decidua of tubal ectopic pregnancy ［J］.Molecular Human Reproduction,2009,15(5):287-294.
[17] EVANS J,D' SYLVA R,VOLPERT M,et al.Endometrial CRISP3 is regulated throughout the mouse estrous and human menstrual cycle and facilitates adhesion and proliferation of endometrial epithelial cells ［J］.Biology of Reproduction,2015,25(4):92-99.
[18] KO WC,SUGAHARA K,SAKUMA T,et al.Copy number changes of CRISP3 in oral squamous cell carcinoma ［J］.Oncology Letters,2012,3:75-81.
[19] RUDI H,KE LL,LENE U,et al.The expression of β-microsemino protein but not CRISP3 is reduced in ovarian cancer and correlates to survival ［J］.Anticancer Research,2012,32:3993-4000.
[20] WANG YY,SHENG N,SHENG Y,et al.Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma［J］.Journal of Cellular Physiology,2019,234(8):1-10.
[21] SCHROYER AL,STIMES NW,ABI SAAB WF,et al.MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells ［J］.Oncogene,2018,37:1031-1040.
[22] GRUPP K,KOHL S,SIRMA H,et al.Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence ［J］.Modern Pathology,2013,26:733-742.
[23] ANNA D,ANDERS E,CHRISTER H,et al.Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3 ［J］.Prostate Cancer Prostatic Dis,2010,13(4):369-375.
[24] ASMANN YW,KOSARI F,WANG K,et al.Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags ［J］.Cancer Research,2002,62(11):3308-3314.